James F Oliviero III's Net Worth
$14.3 Million
Who is James F Oliviero III?
James F Oliviero III has an estimated net worth of $14.3 Million. This is based on reported shares across multiple companies, which include Checkpoint Therapeutics, Inc., Nuvectis Pharma, Inc., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
James F Oliviero III's CIK is 0001434718
Past Insider Trading and Trends
2014 was James F Oliviero III's most active year for acquiring shares with 6 total transactions. James F Oliviero III's most active month to acquire stocks was the month of December. 2022 was James F Oliviero III's most active year for disposing of shares, totalling 12 transactions. James F Oliviero III's most active month to dispose stocks was the month of December. 2014 saw James F Oliviero III paying a total of $648,311.67 for 204,842 shares, this is the most they've acquired in one year. In 2014 James F Oliviero III cashed out on 474,864 shares for a total of $7,301,374.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Checkpoint Therapeutics, Inc. (CKPT) Snapshot price: $2.04
CEO, President and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.19% | -14.95K |
$2.06 | -$12,141.64 | 341.78K |
Feb 28
| |||
Form 4
| -6.51% | -24.85K |
$2.01 | -$23,919.00 | 356.73K |
Feb 1
| |||
Form 4
| +173.50% | 250K |
—
|
—
| 394.09K |
Mar 31
| |||
Form 4
| +2.83% | 3.97K |
$4.82 | -$53,213.20 | 144.09K |
Feb 27 - Mar 2
| |||
Form 4
| -5.33% | -10.26K |
$4.77 | -$48,944.97 | 182.12K |
Feb 1
| |||
Form 4
| -1.95% | -3.82K |
$6.75 | -$25,760.93 | 192.38K |
Jan 10
| |||
Form 4
| -9.73% | -276.00K |
$1.09 | -$301,140.00 | 2.56M |
Jun 17 - Jun 23
| |||
Form 4
| -21.35% | -770.21K |
$2.48 | -$1,909,801.91 | 2.84M |
Jan 1 - Apr 13
| |||
Form 4
| +14.43% | 455K |
—
|
—
| 3.61M |
Jan 31
| |||
Form 4
| -3.63% | -118.79K |
$3.47 | -$412,269.70 | 3.15M |
Feb 4 - Feb 5
| |||
Form 4
| +19.72% | 539K |
—
|
—
| 3.27M |
Jan 6
| |||
Form 4
| +28.01% | 598K |
—
|
—
| 2.73M |
Feb 24
| |||
Form 4
| +29.39% | 485K |
—
|
—
| 2.13M |
Jan 24
| |||
Form 4
| +24.53% | 325K |
—
|
—
| 1.65M |
Jan 30
| |||
Form 4
| +32.50% | 325K |
—
|
—
| 1.32M |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nuvectis Pharma, Inc. (NVCT) Snapshot price: $7.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +183.15% | 18K |
—
|
—
| 27.83K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.92% | -1.94K |
$9.61 | -$18,672.23 | 209.41K |
Jul 6
| |||
Form 4
| +24.51% | 41.61K |
$2.67 | $111,095.33 | 211.35K |
May 12
| |||
Form 4
| -1.09% | -1.88K |
$11.68 | -$21,935.04 | 169.74K |
Apr 6
| |||
Form 4
| +11.91% | 18.27K |
$13.79 | -$77,279.16 | 171.62K |
Jan 4 - Jan 5
| |||
Form 4
|
—
|
0
|
$13.46 | -$111,750.00 | 331.69K |
Dec 10
| |||
Form 4
| -1.73% | -2.69K |
$16.14 | -$43,481.16 | 153.34K |
Oct 3
| |||
Form 4
| -48.03% | -144.24K |
$15.88 | -$2,290,483.56 | 156.04K |
Sep 8
| |||
Form 4
| -0.68% | -2.05K |
$15.75 | -$32,350.50 | 300.28K |
Jul 7
| |||
Form 4
| -0.69% | -2.09K |
$16.46 | -$34,352.02 | 302.33K |
Apr 3
| |||
Form 4
| -17.29% | -188.44K |
$9.34 | -$4,061,341.14 | 901.32K |
Mar 19 - Mar 21
| |||
Form 4
| +3.45% | 16.43K |
$12.57 | -$79,304.13 | 492.86K |
Jan 2 - Jan 3
| |||
Form 4
| -5.17% | -79.50K |
$8.62 | -$1,246,590.00 | 1.46M |
Dec 27 - Dec 30
| |||
Form 4
| -0.26% | -1.48K |
$10.25 | -$15,118.75 | 555.93K |
Oct 3
| |||
Form 4
| -0.26% | -1.44K |
$7.95 | -$11,432.10 | 557.4K |
Jul 5
| |||
Form 4
| -4.99% | -29.36K |
$8.34 | -$244,887.42 | 558.84K |
May 13
| |||
Form 4
| -0.25% | -1.48K |
$6.93 | -$10,284.12 | 588.21K |
Apr 5
| |||
Form 4
| +4.00% | 22.66K |
$2.74 | -$29,753.66 | 589.69K |
Jan 2 - Jan 4
| |||
Form 4
| -0.87% | -4.97K |
$2.72 | -$13,526.56 | 567.03K |
Oct 3
| |||
Form 4
| -0.79% | -4.56K |
$1.99 | -$9,072.41 | 572K |
Jul 3
| |||
Form 4
| +226.55% | 400K |
—
|
—
| 576.56K |
May 21
| |||
Form 4
| -3.00% | -5.46K |
$1.60 | -$8,738.26 | 176.56K |
Apr 5
| |||
Form 4
| +12.91% | 20.81K |
$2.63 | -$18,873.75 | 182.02K |
Jan 2 - Jan 3
| |||
Form 4
| -3.65% | -6.11K |
$2.82 | -$17,191.68 | 161.21K |
Oct 3
| |||
Form 4
| -2.68% | -4.61K |
$4.80 | -$22,132.80 | 167.31K |
Jul 5
| |||
Form 4
| -21.55% | -47.23K |
$4.99 | -$235,682.69 | 171.92K |
Jun 6
| |||
Form 4
| -2.01% | -4.49K |
$5.10 | -$22,899.00 | 219.16K |
Apr 5
| |||
Form 4
| +0.99% | 2.19K |
$4.67 | -$65,678.88 | 223.65K |
Jan 2 - Jan 3
| |||
Form 4
| -37.94% | -135.37K |
$5.02 | -$679,390.23 | 221.46K |
Dec 2 - Dec 6
| |||
Form 4
| -0.34% | -1.21K |
$4.58 | -$5,537.22 | 356.83K |
Oct 4
| |||
Form 4
| -2.72% | -10.00K |
$3.84 | -$38,400.00 | 358.04K |
Aug 20
| |||
Form 4
| -0.33% | -1.21K |
$3.35 | -$4,063.55 | 368.04K |
Jul 6
| |||
Form 4
| -10.10% | -41.50K |
$3.97 | -$164,535.60 | 369.25K |
Jun 8
| |||
Form 4
| -6.45% | -28.33K |
$4.20 | -$307,832.62 | 410.75K |
May 12
| |||
Form 4
| -0.20% | -899.00 |
$3.36 | -$3,020.64 | 439.08K |
Apr 5
| |||
Form 4
| +33.88% | 122.98K |
$2.60 | $59,771.28 | 439.98K |
Jan 2 - Jan 5
| |||
Form 4
| +1.46% | 5.21K |
—
|
—
| 362.96K |
Dec 16
| |||
Form 4
| +0.77% | 2.75K |
$0.90 | $2,471.70 | 357.75K |
Jun 23
| |||
Form 4
| +7.58% | 25K |
$0.40 | $9,925.00 | 355K |
May 22
| |||
Form 4
| +17.86% | 50K |
—
|
—
| 330K |
Jan 2
| |||
Form 4
|
∞
| 280K |
—
|
—
| 280K |
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||